[Familial paroxysmal polyserositis: modern therapeutic possibilities (author's transl)].
Prognosis of familial paroxysmal polyserositis is primarily related to the presence of renal insufficiency due to the amyloidosis. Current treatment of terminal renal failure--haemodialysis and renal transplantation--has increased survival in these patients, but prognosis remains relatively poor because of the extrarenal, mainly cardiac deposits which have had time to develop. Preventive treatment is therefore all that can be hoped for, and initial results of the use of colchicine in this amyloid affection, by Israelian authors, appear encouraging.
D000293:Adolescent; D000686:Amyloidosis / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D003078:Colchicine / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D010505:Familial Mediterranean Fever / Q000150:complications*; D005260:Female; D006801:Humans; D007223:Infant; D007674:Kidney Diseases / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000517:prevention & control*; D016030:Kidney Transplantation; D008297:Male; D011379:Prognosis; D006435:Renal Dialysis
D003078:Colchicine; D004121:Dimethyl Sulfoxide
L'insuffisance rénale de la maladie périodique peut-elle bénéficier de méthodes thérapeutiques modernes?